Impact of mastectomy in women with stage IV HER2+breast cancer.

被引：0
|
作者：
Babar, Arslan
Covut, Fahrettin
Kewan, Tariq Zuheir
Rahman, Shafia
Grobmeyer, Stephen R.
Montero, Alberto J.
机构：
[1] Cleveland Clin, Dept Med, Cleveland, OH 44106 USA
[2] Univ Hosp Case Med Ctr, Seidman Canc Ctr, Adult Hematol Malignancies & Stem Cell Transplant, Cleveland, OH USA
[3] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
[4] Cleveland Clin, Cleveland, OH 44106 USA
[5] Cleveland Clin, NSABP Fdn, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e12515
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12515
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety of trastuzumab in women with HER2+breast cancer.
    Nowsheen, Somaira
    Aziz, Khaled
    Park, Jae Yoon
    Villarraga, Hector R.
    Herrmann, Joerg
    Ruddy, Kathryn Jean
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Impact of race on BluePrint genomic subtyping in HER2+breast cancer.
    Reid, Sonya A.
    Pal, Tuya
    Shu, Xiao-Ou
    Venton, Lindsay
    Whisenant, Jennifer G.
    Hoskins, Kent
    Dias, Eduardo
    Rahman, Rakhshanda Layeequr
    Wei, Jennifer
    Uygun, Sahra
    Singleton, Ciera S.
    Menicucci, Andrea
    Dauer, Patricia
    Audeh, William M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Targeting glucose metabolism in HER2+breast cancer.
    Chang, Simone
    Chesney, Jason
    Trent, John O.
    Telang, Sucheta
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [4] Adjuvant trastuzumab and vinorelbine (TV) for early-stage HER2+breast cancer.
    McLaughlin, Shannon
    Nakajima, Erika
    Isakoff, Steven J.
    Shin, Jennifer
    Moy, Beverly
    Bardia, Aditya
    Kuter, Irene
    Spring, Laura
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Lapatinib-based therapy for women with advanced/metastatic HER2+breast cancer.
    Zekri, Jamal M.
    Al-Foheidi, Meteb Owaish
    Ibrahim, Mohamed Mokhtar
    Darwish, Tarek
    Mahrous, Mervat
    Mansour, Maged
    Rizvi, Azhar J.
    Al Fayea, Turki Mohammad
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] HER2+breast cancer
    Hicks, David G.
    Kulkarni, Swati
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (02) : 263 - 273
  • [7] Breast MRI as a radiomic biomarker of immune enrichment in HER2+breast cancer.
    Kennedy, Laura
    Durenberger, Grace
    Stanton, Sasha E.
    Vinayak, Shaveta
    Dintzis, Suzanne
    Partridge, Savannah C.
    Gadi, Vijayakrishna K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Adjuvant and neoadjuvant trastuzumab in combination with vinorelbine for HER2+breast cancer.
    Esfahani, Khashayar
    Ferrario, Cristiano
    Le, Philippe
    Panasci, Lawrence C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Retrospective study of clinical outcomes in patients with Stage IV HER2+breast cancer undergoing primary breast surgery
    Babar, Arslan
    Al-Hilli, Zahraa
    Covut, Fahrettin
    Chadalavada, Pravallika
    Attia, Doaa
    Behera, Tapas Ranjan
    Montero, Alberto J.
    [J]. BREAST JOURNAL, 2021, 27 (07): : 618 - 620
  • [10] Surgical management of Stage I TN and HER2+breast cancer
    Mamtani, A.
    [J]. CANCER RESEARCH, 2024, 84 (09)
12345